Review Criteria for Hospital Utilization for Patients with Cerebrovascular Disease
Neurol 44:1531-1532, Lanska,D.J.,et al, 1994
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
The "Million Hearts" Initiative - Preventing Heart Attacks and Strokes
NEJM 365:e27, Frieden, T.R.,et al, 2011
Pediatric Moyamoya Disease: An Analysis of 410 Consecutive Cases
Ann Neurol 68:92-101, Kim,S.-K., et al, 2010
Moyamoya Disease and Moyamoya Syndrome
NEJM 360:1226-1237, Scott,R.M. &Smith,E.R., 2009
Treatment of Atherosclerotic Intracranial Arterial Stenosis
Stroke 40:2257-2261, Turan,T.N.,et al, 2009
Intracranial Atherosclerotic Disease: An Update
Ann Neurol 66:730-738, Qureshi,A.,et al, 2009
Statin Treatment and the Occurrence of Hemorrhagic Stroke in Patients With a History of Cerebrovascular Disease
Stroke 39:497-502, Vergouwen,M.D.I.,et al, 2008
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Prospective Cohort Study to Determine if Trial Efficacy of Anticoagulation for Stroke Prevention in Atrial Fibrillation Translates Into Clinical Effectiveness
BMJ 320 :1236-1239,1219, Kalra,L.,et al, 2000
New magnetic Resonance Imaging Methods for Cerebrovascular Disease: Emerging Clinical Applications
Ann Neurol 47:559-570, Neumann-Haefelin,T.,et al, 2000
Consent Issues in the Management of Cerebrovascular Diseases, A Position Paper of the American Academy of Neurology Ethics and Humanities Subcommittee
Neurol 53:9-11, , 1999
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Childhood Leukemia:Central Nervous System Abnormalities During and After Treatment
AJNR 17:295-310, Chen,C-Y.,et al, 1996
Cognitive Impairment & Mortality in a Cohort of Elderly People
BMJ 312:608-611, Gale,C.R.,et al, 1996
Aspirin in Ischemic Cerebrovascular Disease-How Strong is the Case for a Different Dosing Regimen
Stroke 27:756-760, Patrono,C.&Roth,G.J., 1996
Neurologic Aspects of Inflammatory Bowel Disease
Neurol 45:416-421, Lossos,A.,et al, 1995
Stent Placement for Arterial and Venous Cerebrovascular Disease:Preliminary Experience
Radiology 191:441-446, Marks,M.P.,et al, 1994
Prospective Study of Endogenous Tissue Plasminogen Activator and Risk of Stroke
Lancet 343:940-943, Ridker,P.M.,et al, 1994
Compliance with Antiplatelet Therapy in Pts with Ischemic CVD:Assessment by Platelet Aggregation Testing
Stroke 25:2337-2342, Komiya,T.,et al, 1994
Cysticercosis and Cerebrovascular Disease:A Review
JNNP 55:252-254, DelBrutto,O.H., 1992
Critical Carotid and Vertebral Arterial Occlusive Disease and Cough Syncope
Stroke 23:1017-1020, Linzer,M.,et al, 1992
Aspirin in the Prevention of Thrombosis
Medicine 70:161-178, Lekstrom,J.A.&Bell,W.R., 1991
Percutaneous Transluminal Angioplasty (PTA) of Supra-Aortic Arteries Especially in Internal Carotid Artery
Neuroradiology 33:191-194, Kachel,R.,et al, 1991
Diagnosis and Treatment of Ischemic Stroke
JAMA 266:2413-2418, Caplan,L.R., 1991
Diagnosis of Epilepsy
Lancet 336:291-295, Chadwick,D., 1990
Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989
Intracranial Branch Atheromatous Disease:A Neglected, Understudied, and Underused Concept
Neurol 39:1246-1250, Caplan,L.R., 1989
Stroke-1989 Recommendations on Stroke Prevention
Diagnosis, and Therapy, Report of the WHO Force on Stroke and CV Disorders, Stroke 20:1407-143189., , 1989
Aspirin All Round
BMJ 296:307-308, Orme,M., 1988
Secondary Prevention of Vascular Disease by Prolonged Antiplatelet Treatment
Antiplatelet Trailists'Collaboration, BMJ 296:320-3311988., , 1988
Anticoagulant Therapy in Cerebrovascular Disease:Review and Meta-Analysis
Stroke 19:1043-1048, Jonas,S., 1988
Thrombolytic Therapy:Current Status (Second of Two Parts)
NEJM 318:1585-1595, Marder,V.J.&Sherry,S., 1988
Thrombolytic Therapy in Cerebrovascular Disease
Stroke 19:1174-1179, DelZoppo,G.J., 1988
Controversies in the Management of Cerebral Vascular Disease
Neurol 38:1609-1616, Scheinberg,P., 1988
Aspirin for Strokes and Transient Ischaemic Attacks
BMJ 297:995-996, Sandercock,P., 1988
Neurologic Manifestations of AIDS
Medicine 66:407-437, McArthur,J.C., 1987
Current Medical & Surgical Therapy for Cerebrovascular Disease
NEJM 317:1505-1516, Grotta,J.C., 1987
Therapy of Ischemic Cerebral Vascular Disease Due to Atherothrombosis
NEJM 311:27-34, 100-1051984., Kistler,J.P.,et al, 1984
Risk Factors in Stroke, A Statement for Physicians by the Subcommittee on Risk Factors and Stroke of the Stroke Council
Stroke 15:1105-1111, Dyken,M.L.,et al, 1984
The Role of the Neurologist in the Decline of Stroke
Ann Neurol 14:1-7, Whisnant,J.P., 1983
The Natural History of Asymptomatic Carotid Bifurcation Plaques
Stroke 13:459-464, Durward,Q.J.,et al, 1982
Therapy of Ischemic Cerebrovascular Disease
Ann Int Med 93:742-756, Byer,J.A.,et al, 1980
Evaluation & Managment of Stroke
Postgrad Med 59:105, McDowell,F.H., 1976
Occipital Artery-Middle Cerebral Artery, Anastomosis for Cerebral Artery Occlusive Disease
Surg Neurol 2:235, Spetzler,R.,et al, 1974
Carotid Endarterectomies & TIA's
Lancet 51, 1974. (Jan) ., , 1974
Lesions in Cerebrovascular Disease & their Clinical Implications
BMJ 89, Hutchinson,E.C., 1972
Clinicopathologic Conference, Mycobacterium Tuberculosis Meningitis
NEJM 384:166-176, Case 1-2021, 2021
Clinicopathologic Conference, Vascular Ehlers-Danlos Syndrome
NEJM 385:1317-1325, Case 30-2021, 2021